How is Ilumya administered?

Drugs.com

Official answer

by Drugs.com

Ilumya is given as by subcutaneous injection, which means under the skin. Ilumya must be administered by a healthcare professional who will choose an injection site with clear skin and easy access, such as your abdomen (stomach), thighs, or upper arm. Ilumya should not be administered within 2 inches of the navel or where the skin is tender, bruised, red, or affected by psoriasis. It should also not be injected into scars, stretch marks, or blood vessels.

The first two injections of Ilumya are given 4 weeks apart, followed by an injection thereafter once every 12 weeks. Each single-dose prefilled syringe of Ilumya contains 100 mg of tildrakizumab-asmn. Ilumya cannot be self-administered.

In March 2018, the FDA approved Ilumya (tildrakizumab-asmn), a humanized interleukin-23 p19 subunit antagonist (anti-IL-23p19) monoclonal antibody for moderate-to-severe plaque psoriasis in adults who are candidates for systemic treatment or phototherapy (ultraviolet or UV light).

Related medical questions

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords